Axonal degeneration plays a key role in the pathogenesis of numerous neurological disorders including spinal cord injury. After the irreversible destruction of the white matter elements J o u r n a l P r e -p r o o f Journal Pre-proof during the primary (mechanical) injury, spared axons and their supporting glial cells begin to breakdown causing an expansion of the lesion site. Here we mechanistically link external sources of calcium entry through axoplasmic reticulum calcium store depletion that contributes to secondary axonal degeneration through a process called store-operated calcium entry. There is increasing evidence suggesting that store-operated calcium entry impairment is responsible for numerous disorders. Nevertheless, its role following spinal cord injury remains poorly understood. We hypothesize that store-operated calcium entry mediates secondary white matter degeneration after spinal cord injury. We used our previously published model of laser-induced spinal cord injury to focally transect mid cervical dorsal column axons from live 6-8-week-old heterozygous CNPase GFP/+ : Thy1 YFP+ double transgenic murine spinal cord preparations (five treated, eight controls) and documented the dynamic changes in axons over time using twophoton excitation microscopy. We report that one hour delayed treatment with YM-58483, a potent inhibitor of store-operated calcium entry, significantly decreased intra-axonal calcium accumulation, axonal dieback both proximal and distal to the lesion site, reduced secondary axonal "bystander" damage acutely after injury, and promoted greater oligodendrocyte survival compared to controls. We also targeted store-operated calcium entry following a clinically relevant contusion spinal cord injury model in vivo. Adult, 6-8-week-old Advillin-Cre: Ai9 mice were subjected to a mild 30 kdyn contusion and imaged to observe secondary axonal degeneration in live animals. We found that delayed treatment with YM-58483 increased axonal survival and reduced axonal spheroid formation compared to controls (n = 5 mice per group).
Introduction
Spinal cord injury (SCI) is debilitating with significant worldwide socio-economic impact (Kirchberger et al., 2010; Zhang et al., 2013; Chen et al., 2017) . Despite this, current clinically available treatments are inadequate and provide limited benefit. The neurological deficits after SCI are attributable to the extent and location of the primary mechanical insult and a secondary degenerative response. Secondary axonal degeneration occurs after the primary injury as spared axons and other white matter elements (myelin and oligodendrocytes) breakdown causing the initial lesion site to expand (Blight and Decrescito, 1986; Tator and Fehlings, 1991; Sun et al., 2010; Mietto et al., 2015) . Damaged axons often form large, swollen endings (Ramon y Cajal, 1928; Li and Raisman, 1995; Davies et al., 1999) called endbulbs that contain groupings of destabilized microtubules, membranes, and organelles (Bresnahan, 1978; Tom et al., 2004; Erturk et al., 2007) . These "endbulbs" retract or "dieback" from the injury site (Oudega et al., 1999; Hill et al., 2001; Stirling et al., 2004; Stirling et al., 2014a; Orem et al., 2017) making the potential for recovery even more difficult. Although the precise molecular mechanisms that mediate central myelinated axonal "dieback" remain unclear, intra-axonal Ca 2+ dysregulation (Kerschensteiner et al., 2005; Stirling et al., 2014a; Orem et al., 2017) has been shown to play a role in the acute phase after injury, and macrophages in the first few weeks after injury Stirling et al., 2004; Busch et al., 2009; Evans et al., 2014; Hill, 2017) . It is well established that pathological levels of intra-axonal Ca 2+ accumulation contributes to axonal degeneration (Stirling and Stys, 2010; Lingor et al., 2012) , likely through activation of Ca 2+ dependent proteases and subsequent cytoskeletal disassembly (Wang et al., 2012) . After injury, release of Ca 2+ from either the axoplasmic reticulum (AR) or mitochondria can contribute to secondary axonal degeneration following SCI (Stirling et al., 2014a; Villegas et al., 2014; Orem et al., 2017) as well as extracellular Ca 2+ entry (Black et al., 1988; Holtz et al., 1989; Williams et al., 2014) . Although targeting sources of intracellular and extracellular calcium to date has been shown to be highly protective, data from clinical studies have failed to demonstrate benefits (Pointillart et al., 2000) .
Here we mechanistically link a novel source of external Ca 2+ entry mediated by AR Ca 2+ store depletion that greatly contributes to secondary axonal degeneration through a process called store-operated calcium entry (SOCE). SOCE has now been found to be a necessary component in Ca 2+ uptake to not only replenish intracellular stores, but also influence synaptic plasticity and neurotransmitter release (Bouron, 2000; Baba et al., 2003) . Once luminal endoplasmic reticulum (ER) Ca 2+ levels are low, stromal interacting molecule (STIM) proteins 1 or 2 will oligomerize and migrate to ER/plasma membrane junctions where they recruit Orai channel proteins and through direct STIM-Orai interaction, they form a channel pore that allows extracellular Ca 2+ to enter the cell (Moccia et al., 2015; Putney et al., 2017) . Previous work has identified storeoperated calcium channels (SOCC) expressed in spinal astrocytes and dorsal horn neurons with STIM1, STIM2, and Orai1 as the necessary components (Xia et al., 2014; Gao et al., 2016) .
However, at present there is no data of the potential role of SOCE after SCI.
Here we used our previously published model of laser-induced spinal cord injury (LiSCI) (Okada et al., 2014; Stirling et al., 2014a; Orem et al., 2017) to focally transect mid cervical J o u r n a l P r e -p r o o f Journal Pre-proof dorsal column axons from live murine spinal cord preparations and documented the dynamic changes in axons over time using two-photon excitation microscopy. We report that delayed treatment with YM-58483, a potent and specific inhibitor of the SOCC, significantly attenuated axonal dieback both proximal and distal to the lesion site and reduced secondary axonal "bystander" damage acutely after injury. Furthermore, targeting SOCC improved oligodendrocyte survival. We also used a mild, contusive SCI model to observe secondary axon degeneration using two-photon excitation microscopy on live mice in vivo. Inhibiting SOCE with YM-58483 increased axonal survival and reduced axonal spheroid formation compared to controls. These findings suggest that blocking SOCE acutely is cytoprotective and introduce a novel target to prevent pathological Ca 2+ entry following SCI.
Materials and Methods

Ex vivo spinal cord imaging model
All experiments were conducted in accordance with the University of Louisville Institutional Animal Care and Use Committee, adhering to the Guide for the Care and Use of Laboratory Animals. Adult 6-8 week old (both sexes), heterozygous CNPase GFP/+ : Thy1 YFP+ double transgenic mice and C57Bl/6J (Jax Labs, Bar Harbor, ME) were bred in house. CNPase GFP/GFP mice (Yuan et al., 2002) were in house and originally provided by Dr. Gallo. Thy1 YFP+ mice (B6.Cg-Tg(Thy1-YFP)16Jrs/J, The Jackson Laboratory, Bar Harbor, ME) have been previously characterized and express high levels of YFP in greater than 80% of DRG neurons (Feng et al., Inc., Lake Forest, IL), perfused transcardially (1 ml/ min) with ice cold low Ca 2+ artificial cerebrospinal fluid (aCSF, in mM: NaCl 126, NaHCO 3 26, KCL 3, NaH 2 PO 4 1.25, MgSO 4 2, CaCl 2 0.1, and D-Glucose 10), and bubbled in 95% O 2 /5% CO 2 to keep the spinal cord viable during the dissection. The whole cords and vertebral column were then placed in a customized imaging chamber (RC-27L Large Bath Chamber with Slice supports; Warner Instruments, Hamden, Connecticut; attached to a VWR Micro Slide; catalog number 48311-703; VWR International, LLC, Radnor, Pennsylvania). The perfusion was slowly changed to oxygenated 2 mM Ca 2+ aCSF (in mM: NaCl 126, KCl 3, CaCl 2 ·2H 2 O 2, NaH 2 PO 4 1.25, MgSO 4 2, NaHCO 3 26, D-Glucose 10). The temperature of the aCSF was held constant at 37°C by an inline heater (Warner Instruments). Importantly, using this experimental perfusion system, the spinal cord remained viable up to 12 hr after isolation based on morphological observation of axons, oligodendroglia, and myelin as previously reported (Okada et al., 2014) .
Microscopy
Time-lapse images of fluorescently labeled spinal cords were obtained using a commercial A1 R MP + multiphoton confocal microscope (Nikon Instruments Inc., Melville, NY) and Elements software (Nikon Instruments Inc.). Briefly, the midcervical level of the spinal cords were aligned under a 25X, 1.1 NA objective and excited with a wavelength of 950 nm (~17 mW measured at the exit of the objective) for simultaneous GFP and YFP imaging. The fluorescence emitted was filtered through appropriate dichroic and bandpass filters to isolate the fluorescent emission of the fluorophores as previously described (Okada et al., 2014) .
Laser-induced SCI
Baseline time-lapse recordings of the middle of the cervical enlargement were obtained 30 min to 1 hr after initial alignment under the two-photon microscope. Using Nikon software J o u r n a l P r e -p r o o f Journal Pre-proof (Elements) , the area of the proposed ablation site within the gracile fasciculus was magnified 30.3X (~20 μm diameter) and the laser wavelength tuned to 800 nm, ~100 mW for 5 complete passes (6.2 µs pixel dwell time), to produce a highly focal and intense laser pulse to completely transect dorsal column axons. After ablation, the laser wavelength was tuned to 950 nm, magnification decreased to 2.08x and power reduced to ~17 mW as detailed above for time-lapse recordings. If the intended primary ablated fibers were not completely transected the preparation was discarded.
Dye Loading of Live Ex Vivo Spinal Cords
To measure Ca 2+ changes in axons, C57Bl/6J mouse spinal cords were dissected using the same protocol as above; however, before being placed under the microscope, the cords were kept in low Ca 2+ aCSF while micropipette tips coated with dextran-conjugated Alexa 594 (10,000 MW, D-22913, Life Technologies Inc.) as an axonal reference and the Ca 2+ indicator dextranconjugated Oregon Green 488 BAPTA-1 (10,000 MW, O-6798, Life Technologies Inc.) were placed into the dorsal columns at the level of the gracile nucleus. The tissue was allowed to uptake the dye for 2 hr to delineate axon profiles while being incubated in oxygenated low Ca 2+ aCSF.
Contusive SCI and In Vivo Imaging Model
Adult, 6-8-week-old double transgenic Advillin-Cre:Ai9 mice (both sexes) that express tdTomato in sensory neurons were bred in house (gift from Dr. Jeffrey C. Petruska). The "floxed" tdTomato is expressed exclusively in sensory neurons (Zurborg et al., 2011) including DRG neurons that project their axons within the ascending dorsal columns and therefore are easily visualized with in vivo two-photon excitation spinal cord imaging. These animals were anesthetized with isoflurane (3-5% for induction and 1.5% for maintenance; Vetland Medical J o u r n a l P r e -p r o o f Journal Pre-proof Sales & Services LLC; Louisville, KY). Body temperature was maintained at 37 °C throughout the surgeries and artificial tear ointment (Akorn Inc.) was used to protect the eyes during surgery. After skin incision and muscle separation, a custom-made implantable imaging chamber (titanium 3D-printed chambers modified from (Farrar et al., 2012) and designed in-house) that is composed of two sidebars and a top plate was firmly positioned securely around the exposed spinal column and installed prior to laminectomy. A laminectomy was performed at T12 and the exposed spinal cord was covered with an inert gel to facilitate live imaging and prevent drying of the cord. The implantable chamber allows for chronic time-lapse intravital imaging of the spinal cord in the same animal without complications due to repeated surgery (Farrar et al., 2012) . The animals were then aligned under a 25X, 1.1 NA objective and excited with a wavelength of 950 nm (~17 mW measured at the exit of the objective) equipped to an A1 R MP + multiphoton confocal microscope (Nikon Instruments Inc., Melville, NY) and imaged using Elements software (Nikon Instruments Inc.). Once baseline images were obtained, mice received a mild, 30 kdyn contusive-SCI using the Infinite Horizon Impactor Device (Precision Systems and Instrumentation, LLC, Lexington, KY). Following contusion, a piece of coverglass was sealed over the exposed cord and animals were allowed to recover. They were administered lactated ringer's solution (2cc, SC) to replenish electrolytes and fluids, buprenorphine (Buprenex; 0.1 mg/kg, sc., twice daily) to minimize pain, and gentamycin (Gentafuse; 0.1 ml, sc., every day) to prevent infection. Animals were anesthetized and imaged at the contusion site at 24 hr post-SCI. 
Intrathecal injection
The adult, double transgenic Advillin-Cre: Ai9 mice that received a mild contusive-SCI were anesthetized with isoflurane (3-5% for induction and 1.5% for maintenance), shaved near the base of the tail, and the surgical site prepared using Betadine and 70% alcohol. Artificial tear ointment (Akorn Inc., Lake Forest, IL) was used to protect the eyes during surgery. After skin incision and muscle separation to confirm location of the L6 spinous process, a 30 G, 0.5 inch needle (connected to a 25 µl Hamilton syringe) was inserted between the groove of the L5 and L6 vertebrae as previously described (Njoo et al., 2014) . A tail flick was used as a confirmation that the needle entered the intradural space and 10 µl of solution was slowly administered. Once injection was performed, the muscle was closed and the skin incision was stapled.
Image Analysis
To quantify axonal retraction/ dieback, and secondary axonal loss ('bystander' loss of adjacent axons that survived the initial ablation but degenerated over time), time-lapse large image recordings (123 μm wide by 600 μm in length, centered at the ablation site) of the spinal cord dorsal columns were collected in z-stacks (1.5 µm/step size; 0.241 µm/pixel) at baseline, 5 min, 30 min, 1 hr, 2 hr, 3 hr, 4 hr and 6 hr after laser-induced SCI and the 4D image data were then imported into ImageJ (written for NIH) for visualization and analysis. The distance of axonal retraction/ dieback of individual axons proximal (caudal, potential sites of growth cone formation and axonal regeneration) and distal (rostral, destined to undergo Wallerian degeneration) to the ablation site over time was measured by individuals blind to treatment using J o u r n a l P r e -p r o o f Journal Pre-proof a distance tool in ImageJ (as detailed in Figure 1I ). Only endbulbs that were clearly connected to a proximal axonal stalk were included in the analysis to avoid including fragments of degenerating axons. The distance between the endbulb and the ablation edge was recorded, analyzed, and expressed as median, 5 th , 10 th , 25 th , 75 th , 90 th and 95 th percentiles as box and whisker plots (SigmaPlot Version 11, Systat Software Inc., San Jose, CA). To determine whether YM-58483, an antagonist of SOCC reduced axonal dieback, a total of n = 56 to 458 axonal endbulbs per treatment group were measured from 5-8 animals per group, analyzed, and expressed as above. To quantify 'bystander' loss of axons adjacent to the ablation site that survived the initial injury, but then succumbed to secondary degeneration, individuals blind to treatment measured the width of axonal loss using a distance tool on five adjacent images at the center of the ablation site. The width of axonal loss was calculated as the total lesion width (distance between the closest intact axons on both sides of the ablation site) minus the ablation site width (contains primary injured axons). A total of n = 5-6 ablation sites from 5-6 animals per group were analyzed and expressed as mean ± SD.
To measure oligodendrocyte survival after LiSCI, images were collected as above and analyzed using ImageJ. Z-stacks were compiled into a single image using the maximum intensity projection tool for the GFP channel, which shows expression of oligodendrocytes.
Oligodendrocytes were only counted if a cellular outline was visible or if the presence of a nucleus was observed. Counts were performed by individuals blind to treatment groups. To account for variability in oligodendrocyte numbers between preps and groups at baseline within the standard imaging window (123 μm wide by 600 μm in length), data were normalized to uninjured baseline values set at 100%. Data were graphed as mean ± SD for both the caudal and J o u r n a l P r e -p r o o f Journal Pre-proof rostral segments of the spinal cord (divided by the ablation site). A total of n = 5-8 ablation sites was analyzed per group.
To assess changes in intracellular calcium levels, a 25 m 2 grid was overlaid on the images and axons were traced along their lengths using the straight-line tool in ImageJ. Axons were traced for 30 grid spaces (150 m) with each grid space having its own ROI (region of interest) that is approximately 5 m long. A total of n = 3 animals per group were analyzed. Nine to ten uninjured axons and axons undergoing dieback were traced from each image for a total of 29 control axons and 30 treated axons. The axons were measured and the mean grey fluorescence values from the calcium indicator channel minus background was determined by investigators blind to treatment. The data are represented as a ratio ΔF/F 0 of the change in intensity (F) over the initial intensity at baseline (F 0 ). The change in calcium fluorescence was then graphed against distance for each axon and an area under the curve analysis was performed using SigmaPlot Version 11 (Systat Software Inc., San Jose, CA). Data were represented as median area under the curve ± 25 th percentile.
To quantify the percentage of surviving axons after a mild, contusive-SCI, a region with good visibility was chosen in the standard imaging window (950 µm wide by 1385 µm long) and a perpendicular line (ImageJ) was drawn from the dorsal vein to the beginning of the roots (~250 μm) at the epicenter of the contusion site. Axons that touched this line were manually counted, divided by the length of the line, and compared to the same animal's pre-injury baseline. Axons were examined to the extent possible throughout the image to ensure that no end bulbs were present for a single axon. If an end bulb was seen, the axon wasn't counted as surviving. 
Western Blot
For tissue collection, mice were euthanized with an overdose of 100 mg/mL ketamine (Hospira Inc., Lake Forest, IL) / 10 mg/mL xylazine (Akorn Inc., Lake Forest, IL). A 1.5 cm section of the lumbar spinal cord containing the lesion was collected at 24 hr, and 48 hr after contusive-SCI and from naïve (no surgery) controls (n = 3-4/ group). Spinal cord samples were homogenized in tissue lysis buffer (50mM Tris base pH 7.4, 5mM EGTA, 100mM NaCl, and 1%Triton x-100) containing protease inhibitor cocktail (1:100, Roche) and then left on ice for 30-40 min before being centrifuged (Centrifuge 5418, Eppendorf, Hauppauge, NY, USA) at 13,000 rpm for 40 min at 4C. The protein concentration was then assessed using the Pierce BCA Protein Assay kit J o u r n a l P r e -p r o o f Journal Pre-proof (Thermo-Scientific) . Equal amounts of 30 µg of protein with sample buffer were heated 95-100C for 5 min then loaded and ran on a 8% SDS-PAGE gel with Tris-Glycine running buffer at 150V for 60 min (Bio-Rad) before being transferred onto a 0.2 micron nitrocellulose membrane (88024, Thermo-Scientific) at 100V for 45 min (Bio-Rad). The membranes were then blocked in 5% (w/v) nonfat dry milk powder in TTBS (20mM Tris-base, 150mM NaCl, pH 7.5) with 0.1% Tween 20 for 1 hr at room temperature and then incubated in 5% (w/v) nonfat dry milk powder in TTBS with the following antibodies: STIM1 (1:1000, SAB3500365, rabbit anti-STIM1 (Sigma-Aldrich, St. Louis, MO, USA)), STIM2 (1:2000, 21191-1-AP, rabbit anti-STIM2 (Proteintech, Rosemont, IL, USA)), and GAPDH (1:50,000, MAB374, mouse anti-GAPDH (Millipore, MA,USA)) overnight at 4C. The membranes were then washed in 1X TTBS three times for 5 min and incubated in 5% (w/v) dry milk powder in TTBS with horseradishperoxidase conjugated goat anti-rabbit IgG (H +L) (1:10,000, 401315, Ig HRP Rabbit (Millipore, MA, USA)) or horseradish-peroxidase conjugated goat anti-mouse IgG (H+L) (1:10,000, 401253, Goat Anti-Mouse IgG (Millipore, MA, USA)) for 1 hr at room temperature. The membranes were then washed in 1X TTBS three times for 5 min. The immunoreactivity of the proteins was detected using chemiluminescence by the SuperSignal West Pico Chemiluminescent Substrate kit (Cat. No. 34080, Thermo-Scientific). Film was developed using an X-ray machine and then digitized before densitometric quantification was calculated using ImageJ. A ratio was generated between proteins and GAPDH as the internal control. Groups were then compared using Sigmaplot 11 (Sigmaplot 11 Software, Systat Software Inc.).
Statistics
Axonal dieback data were analyzed using a Kruskal-Wallis one-way ANOVA on ranks with Dunn's method of multiple comparisons as the data failed normality. Bystander axonal loss was J o u r n a l P r e -p r o o f analyzed using a repeated measures ANOVA with Holm-Sidak method of multiple comparisons.
Oligodendrocyte survival was analyzed using an independent two-tailed t-test. The areas under the curve obtained from each axon's change in calcium were analyzed by a Mann-Whitney Rank sum test as the data failed normality. Axonal spheroid formation and axon survival 24 hr post a mild contusive-SCI in vivo were analyzed using an independent two-tailed t-test. For Western blot analysis, a one-way ANOVA with Holm-Sidak method of multiple comparisons were used.
If the data failed normality, a Kruskal-Wallis one-way ANOVA on rans with Dunn's method of multiple comparisons was used. Test statistics, degrees of freedom, and exact p values are reported for each test in the results in the following form H,Q,F,U,or t (degrees of freedom) , p value . Probability values p < 0.05 were considered significant.
Data availability
All raw data is available on request
Results
To visualize secondary axonal degeneration in real-time, we used our two-photon LiSCI model on live ex vivo whole mouse spinal cords that express GFP in oligodendrocytes and YFP in axons (Okada et al., 2014; Stirling et al., 2014b; Stirling et al., 2014a ). An approximate 20 µm by 20 µm region centered within the gracile fasciculus was irradiated with the focused laser to produce a highly reproducible lesion across many preparations, as shown in Fig. 1A-H . This approach allowed us to view axon and oligodendrocyte degeneration simultaneously as these dynamic events are occurring in real-time.
SOCE promotes axonal dieback
To assess the role of SOCE on axonal dieback after LiSCI, we blocked calcium reuptake via SOCE with YM-58483 (500 nM administered 1 hr post-LiSCI and continuously perfused for J o u r n a l P r e -p r o o f 5 hr), a SOCC antagonist, and assessed its effect on axonal dieback. As shown in Figure 1 , we found that blocking SOCE with YM-58483 significantly (H = 458.43 (7) , p = <0.001) reduced axonal dieback beginning at 2 hr post and continuing until 6 hr post LiSCI proximally (24.24  15.24 m; median  25 th percentile, with YM-58483 versus 33.6  20.16 m with aCSF (vehicle control) at 2 hr post-SCI, Q = 3.58 (See Fig. 1E, F, J) , 29.4  17.64 m with YM-58483 versus 40.64  23.68 m with aCSF at 4 hr post-SCI, Q = 4.39 (Fig. 1J) , and 33.7  18.96 m with YM-58483 versus 44.96  25.6 m with aCSF at 6 hr post-SCI, Q = 3.91 ( Fig. 1G, H, J) ).
Blocking SOCE with YM-58483 also significantly (H = 548.18 (7) , p = <0.001) reduced axonal dieback at 4 hr post LiSCI distally (33.98  24.34 m with YM-58483 versus 42.60  29.36 m with aCSF, Q = 3.63; see Figure 1K ). Importantly, there are no visible endbulbs or axonal pathology prior to LiSCI at baseline ( Figure 1A, B) suggestive that the ex vivo model does not induce overt damage and no difference in axonal dieback between groups prior to the delayed treatment ( Figure 1C, D) . To confirm that SOCE proteins are localized to axons following ablation, we performed immunofluorescence staining on tissue sections isolated from LiSCI spinal cord preparations. We reveal that Orai1, Orai2, Orai3, STIM1, and STIM2 spatially overlap with YFP + dorsal column axons at 6 hr after LiSCI ( Supplementary Fig. 1 ). These results suggest that calcium reuptake by SOCE contributes to axonal dieback following SCI.
SOCCs contribute to secondary bystander degeneration
To determine the effect of SOCE on secondary axonal degeneration, we measured the width of the lesion (subtracting the ablation width) as an indicator of bystander axon degeneration. These are axons that were spared from the initial injury, but then succumb to a delayed breakdown over time (Stirling et al., 2014a; Orem et al., 2017) as shown here in Figure   2C -F. Baseline images (Figure 2A, B ) reveal no visible damage to fibers prior to LiSCI. Delayed
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Journal Pre-proof treatment with YM-58483 significantly (F = 24.77 (9, 138) , p = <0.001) reduced the width of axonal loss (i.e., increased the amount of "bystander" spared axons) at 4 and 6 hr post LiSCI (13.51  3.87 m; mean  SD, with YM-58483 versus 20.64  4.70 m with aCSF at 4 hr post-SCI, t = 4.30, p = <0.001; see Figure 2G , and 15.75  5.93 m with YM-58483 versus 21.59  5.98 m with aCSF at 6 hr post-SCI, t = 3.37, p = <0.001; Figure 2E, F, G) . These results suggest that SOCE plays a role in secondary bystander axon degeneration.
SOCE inhibition promotes oligodendrocyte survival
Using mice that label GFP in oligodendrocytes (Yuan et al., 2002) , we were able to examine their survival after LiSCI. Oligodendrocytes were counted at baseline ( Figure 3A, B) and 6 hr post-LiSCI ( Figure 3C, D) , and 6 hr counts were normalized as percent survival from baseline values. As shown in Figure 3 , delayed treatment with YM-58483 beginning at 1 hr post LiSCI, significantly (p<0.05) decreased oligodendrocyte degeneration at 6 hr post-SCI both proximally (12  4%; mean  SD, with YM-58483 versus 24  6% with aCSF, t = 4.09 (11) , p = 0.002; See Fig. 3C , D, E) and distally (9  7% with YM-58483 versus 35  19% with aCSF, t = 2.79 (11) , p = 0.018; See Fig. 3C , D, F) from baseline ( Figure 3A, B) values. These results indicate that SOCE may contribute to oligodendrocyte loss after SCI.
SCI-induced intra-axonal calcium levels are decreased with SOCE inhibition
To assess dynamic changes in intra-axonal Ca 2+ following SCI, we loaded axon cylinders with the membrane-impermeable Ca 2+ indicator Oregon Green 488 BAPTA-1 dextran (10,000 MW) and an axonal tracer, dextran-conjugated Alexa 594 (10,000 MW) (Stirling et al., 2014a) . Figure 4 Figure 4K ). These results show that inhibiting SOCE through blockage of the SOCC decreases intra-axonal calcium concentrations after LiSCI. They also highlight the fact that greater calcium accumulation in axons coincides with greater axonal degeneration after injury.
As shown in
SOCE inhibition diminished secondary axonal degenerative responses following contusive-SCI in vivo.
To confirm the above results in a clinically-relevant model of SCI in vivo, we assessed secondary degenerative responses following a mild, contusive-SCI (30 kdyn). We used adult male and female, double transgenic Advillin-Cre:Ai9 mice that express "floxed" tdTomato in their dorsal columns. We imaged these animals in vivo using 2-photon excitation microscopy prior to and post contusion ( Figure 5A ). The SOCC antagonist YM-58483 was administered intrathecally at 3 hr and 24 hr post-SCI. Delayed YM-58483 treatment resulted in significantly more axonal survival (p < 0.05) from baseline at 24 hr post-SCI compared to vehicle injected controls (56.42  11.00% with YM-58483 versus 39.0  12.31% for vehicle, t = -2.36 (8) , p = J o u r n a l P r e -p r o o f Journal Pre-proof 0.04, n = 5 mice per group, Figure 5B ). Delayed YM-58483 also revealed significantly less axonal spheroid formation (p < 0.05) compared to vehicle controls (142.49  65.06; mean  SD, with YM-58483 versus 287.58  87.86 for vehicle control, t = 2.97 (8) , p = 0.02, n = 5 mice per group, Figure 5C ). These results further confirm the above ex vivo results and show that inhibiting SOCE at 3 hr following a T12 mild, contusive SCI decreases secondary axonal degenerative responses in a clinically relevant model.
STIM1 and -2 are upregulated after SCI
Previous studies have shown that SOCE proteins are expressed in the spinal cord (Xia et al., 2014; Gao et al., 2016) ; however, whether their expression changes after SCI in vivo remains unknown. By taking spinal tissue from mice from different groups: naïve, 24 hr, or 48 hr following a T12 mild contusive-SCI, we were able to measure protein expression level changes for STIM1 and STIM2. As shown in Figure 6A , B, STIM2 protein expression is significantly (F = 93.25 (2, 6) , p = <0.001) increased at both 24 hr post-SCI (0.96 ± 0.073, mean ± SD, 24 hr post-SCI versus 0.074 ± 0.092 in naïve animals, t = 13.50, p = <0.001) and 48 hr post SCI (0.40 ± 0.077 at 48 hr post-SCI versus 0.074 ± 0.092 in naïve animals, t = 4.96, p = 0.003) compared to naïve groups. By 48 hours post-SCI, STIM2 protein expression has significantly decreased from its levels at 24 hours post-SCI (0.96 ± 0.073, mean ± SD, at 24 hr post-SCI versus 0.40 ± 0.077 at 48 hr post-SCI, t = 8.54, p = <0.001; See Fig. 6B ). In distinction, we found a significant (H=6.71 (2) , p= 0.013) increase in STIM1 protein levels at 48 hr after SCI (1.68 ± 0.992; median 25% at 48 hr post-SCI versus 0.12 ± 0.031 in naïve animals, Q = 2.378, p = <0.05) versus naïve controls ( Figure 6C, D) . Collectively, these results indicate that SOCE is upregulated in the injured spinal cord in vivo presumably to replenish calcium to axons and glia. However, over- 
Discussion
Here we show for the first time that SOCE contributes to secondary white matter degeneration following SCI, i.e. axonal dieback, "bystander" axonal degeneration, and oligodendroglia loss using an ex vivo model of LiSCI as well as axonal survival and spheroid formation using a clinically-relevant in vivo contusion model. In accordance, delayed treatment with YM-58483, an inhibitor of SOCE, decreased axonal dieback both proximal and distal to the injury and reduced secondary "bystander" axon and oligodendrocyte degeneration. In addition, intra-axonal calcium levels were also diminished after injury with delayed YM-58483 treatment in axons retracting from the lesion site. We also found that delayed treatment with YM-58483 decreased axonal survival and spheroids formation compared to vehicle control at 24 hrs post contusive-SCI. These results support previous findings showing that once calcium is released from axoplasmic reticulum through RyRs or IP 3 Rs (Orem et al., 2017) , SOCE activates and brings more calcium into the cell thus propagating the damage. This could point to a shared mechanism in the system and connection between different calcium pathways that may enhance secondary axonal degeneration after SCI. SOCE as a mediator of pathological Ca 2+ levels in white matter is highly relevant for SCI as calcium dysregulation has been identified as a prominent contributor to axonal injury (Banik et al., 1987; Kerschensteiner et al., 2005; Knoferle et al., 2010; Stirling and Stys, 2010; Stirling et al., 2014a) . In agreement, following SOCE inhibition, we found diminished axonal J o u r n a l P r e -p r o o f Journal Pre-proof dieback in fibers both proximal and distal to the lesion ( Figure 1J and 1K) as well as a decrease in secondary "bystander" axonal degeneration (Figure 2 ). We also found less spheroid formation and increased axonal survival 24 hr post contusive-SCI ( Figure 5 ). Temporarily preventing the axons ability to refill its internal stores through SOCE, may be a necessary addition to existing therapeutic strategies to prevent pathological Ca 2+ accumulation and thereby protect axons from secondary degeneration.
Intracellular calcium overload has also been linked to oligodendrocyte degeneration and demyelination (Butt, 2006; Mifsud et al., 2014) . For instance, in the hypoxic-ischemic model of white matter degeneration, overstimulation of neurotransmitter receptors cause cytosolic calcium levels to rise (Mifsud et al., 2014) , and is worsened due to overactivation of voltage-gated calcium channels in the plasma membrane, i.e. AMPA/kainate receptors, and the reversal of the Na + /Ca 2+ exchange pump (Matute et al., 2006) . The excessive amount of calcium can become trapped in mitchondria resulting in mitochondria dysfunction, leading to cell death by apoptosis or necrosis (Mifsud et al., 2014) . SOCE has also been shown to regulate cytosolic calcium levels in oligodendrocytes in response to endoplasmic reticulum store depletion by calcium release from IP 3 R/RyRs (Simpson and Russell, 1997) . Here our results show that by inhibiting SOCE after an LiSCI, there is significantly greater oligodendrocyte survival compared to controls at 6 hr post injury (Figure 3 E,F) . Although, blocking SOCC after injury may not eliminate all the known mechanisms for calcium entry into cells, the improved oligodendrocyte survival shown here suggests SOCE may play a prominent role in calcium-induced degeneration.
Improper calcium homeostasis has also been observed in neurodegenerative disorders.
For example, in Alzheimer's disease (Bojarski et al., 2008) patients' neurons experience higher levels of calcium (Murray et al., 1992) and calcium-dependent enzymes (Nixon et al., 1994) , i.e.
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Journal Pre-proof calpains (Ma, 2013) , which alter the neurons' function compared to healthy controls. Recent evidence has shown that neurons experiencing this calcium overload are in close proximity to beta-amyloid plaques, a pathological feature of the disease (Kuchibhotla et al., 2008) . Similar to Alzheimer's Disease, calcium overload occuring in dopaminergic neurons in patients with Parkinson's Disease can also activate calpains (Michel et al., 2016) , which are known to induce cleavage of the protein cdk5 that expedites dopaminergic neuronal cell death (Smith et al., 2003) .
Coinciding with these models, calcium overload also occurs in axons after spinal cord injury.
Following injury, the proper machinery for regulating calcium levels within the axon likely become ineffective, yielding a higher than normal concentration in damaged fibers, visible via the Oregon Green 488 BAPTA-1 dextran dye ( Figure 4A-H) . Delayed treatment with YM-58483 was able to significantly diminish intra-axonal calcium concentrations following SCI compared to controls. This may reveal SOCE as a contributor to the intra-axonal calcium overload that occurs after SCI.
Although we show in this work the involvement of SOCE in secondary degeneration after SCI, until present there has been no other studies assessing the role of these proteins following SCI. However, a role for these proteins has been demonstrated in other neurodegenerative models. In agreement, expression of STIM1 and Orai proteins were upregulated in rat hippocampal neurons after exposure to a global cerebral ischemia, leading to an excessive calcium influx resulting in a non-excitotoxic mechanism for ischemic neuronal injury . In addition, STIM1 proteins have been implicated in an in vitro et al., 2014) . In Alzheimer's Disease, STIM2 proteins are diminished in hippocampal mushroom dendritic spines resulting in almost complete absence of SOCE and diminished spine density (Sun et al., 2014; Zhang et al., 2016) , while the opposite occurs in Huntington's Disease as STIM2 proteins are over expressed (Wu et al., 2011) .
STIM2 proteins are also overexpressed after TBI (Rao et al., 2015) . Using shRNA to downregulate the protein improved neuronal survival in both in vitro and in vivo models by decreasing SOCE-mediated calcium influx and retaining mitochondrial function (Rao et al., 2015) . Similarily, we found differential increases of STIM1 and -2 after contusive injury to the spinal cord at 24 hr and 48 hr-post SCI (Figure 6B, D) . In agreement, STIM2 is known to have a lower affinity to Ca 2+ and have a higher sensitivity to ER Ca 2+ changes than STIM1 (Brandman et al., 2007) therefore it may become active more quickly to replenish slightly depleted Ca 2+ stores (Zhou et al., 2009) . STIM1 is slower to activate as it requires a greater depletion of the ER store (Brandman et al., 2007) . Another possible mechanism for the difference in protein expression after SCI can be attributed to their activation in infiltrating immune cells that are well known to populate the injury site following SCI. In support, STIM1 and STIM2 loss-of-function studies have shown that both proteins regulate neutrophil functions (Demaurex and Saul, 2018) and as shown here, are expressed at peak neutrophil infiltration following SCI (i.e. 24 hr) (Stirling and Yong, 2008) .
STIM proteins have been shown to be necessary for macrophage recruitment and cytokine release both in vivo and in vitro in a model of peritonitis and LPS-induced inflammation where a total knockout of STIM2 showed significantly decreased number of macrophages and reduced TNF, IL-6, and IL-1 levels compared to wildtype (Sogkas et al., 2015) . Interestingly, STIM1 knockout was found to not have a significant effect on either process, but was shown to J o u r n a l P r e -p r o o f be important for macrophage mediated phagocytosis (Sogkas et al., 2015) . STIM2 is shown to be involved in phagocytosis as well but to a lesser extent than STIM1. Taken together, these studies support the potential for a differential expression of STIM proteins after a clinically-relevant contusive-SCI; However, the effects on SOCE inhibition in vivo may include modulation of immune cell function in the injured spinal cord, as well as direct effects on axons and glia as revealed in the ex vivo LiSCI model. Further work investigating the specific role of STIM and Orai proteins after SCI in immune effector cells as well as axons and glia is therefore warranted.
The ex vivo model of spinal cord injury used here has been previously documented (Okada et al., 2014; Stirling et al., 2014a; Orem et al., 2017) and is advantagous as it allows precise visualization of the dynamic events of axons and glia occuring after SCI. As shown in Figures 1-2 , the LiSCI model induces axonal endbulb formation, axonal dieback and spheroid formation. In order to visualize these dynamic events, we utilitzed two-photon excitation microscopy as it offers superb submicron resolution imaging at a greater depth without overt phototoxicity (Denk et al., 1994) . This is especially important as imaging white matter can be problematic due to the light scattering properties of myelin which limits the resolution of the images at depths deeper than ~100 microns. Thus, some dorsal column fibers will likely not be visualized using this method. Nevertheless it is still a useful model for studying the dynamic changes in axonopathy in a small controlled environment to tease out direct effects on white matter injury.
To further strengthen our results from the ex vivo spinal preparation which is also limited due to a lack of an intact circulatory system and associated immune response to trauma, we used a clinically-relevant contusive model of SCI as it is comparable to human SCI (Young, 2002; Verma et al., 2019) . In agreement with the results obtained ex vivo, we show that by inhibiting J o u r n a l P r e -p r o o f SOCE with YM-58483, there is a decrease in axonal spheroid formation and an increase in axonal survival ( Figure 5 ). These results demonstrate the potential therapeutic benefit of targeting SOCE after SCI as it lessens secondary axonal degeneration.
In summary, we unveil a novel mechanism of pathological Ca 2+ accumulation in white matter suggesting that once SOCE proteins become activated after injury, they further enhance secondary degeneration through continual calcium reuptake into the axons and oligodendroglia. Zurborg S, Piszczek A, Martinez C, Hublitz P, Al Banchaabouchi M, Moreira P, Perlas E, Heppenstall PA (2011) Generation and characterization of an Advillin-Cre driver mouse line. Mol Pain 7:66. 
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